These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 699334

  • 1. The quantitative determination of 5-S-cysteinyldopa and dopa in normal serum and in serum from patients with malignant melanoma by means of high-pressure liquid chromatography.
    Hansson C, Edholm LE, Agrup G, Rorsman H, Rosengren AM, Rosengren E.
    Clin Chim Acta; 1978 Sep 15; 88(3):419-27. PubMed ID: 699334
    [Abstract] [Full Text] [Related]

  • 2. 5-S-Cysteinyldopa and dopa in serum during treatment with 8-methoxypsoralen and UVA light.
    Hansson C, Rorsman H, Rosengren E, Tegner E.
    Acta Derm Venereol; 1981 Sep 15; 61(3):251-5. PubMed ID: 6167110
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Plasma 5-S-cysteinyldopa differentiates patients with primary and metastatic melanoma from patients with dysplastic nevus syndrome and normal subjects.
    Peterson LL, Woodward WR, Fletcher WS, Palmquist M, Tucker MA, Ilias A.
    J Am Acad Dermatol; 1988 Sep 15; 19(3):509-15. PubMed ID: 3139723
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Automated high-performance liquid chromatographic determination of 5-S-cysteinyl-3,4-dihydroxyphenylalanine in urine.
    Kågedal B, Källberg M, Arstrand K, Hansson C.
    J Chromatogr; 1989 Jul 07; 473(2):359-70. PubMed ID: 2504759
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Improved method for analysis of cysteinyldopa in human serum.
    Arstrand K, Kullman A, Andersson R, Rasmuson T, Kågedal B.
    Scand J Clin Lab Invest; 2004 Jul 07; 64(6):559-64. PubMed ID: 15370461
    [Abstract] [Full Text] [Related]

  • 11. Cysteinyldopa isomers and dopa in lesions and urine of Japanese patients with malignant melanoma.
    Morishima T, Tatsumi F, Fukada E, Saito M, Fujita M, Nagashima N, Hanawa S.
    Arch Dermatol Res; 1983 Jul 07; 275(2):76-9. PubMed ID: 6409012
    [Abstract] [Full Text] [Related]

  • 12. Quantitative determination of 5-S-cysteinyldopa, dopa and dopamine in the urine by means of high-performance liquid chromatography. A comparison with data obtained by means of fluorometry.
    Morishima T, Saito M, Hanawa S.
    J Dermatol; 1981 Aug 07; 8(4):301-4. PubMed ID: 6795251
    [No Abstract] [Full Text] [Related]

  • 13. 5-S-cysteinyldopa in the urine of melanoma patients.
    Agrup G, Agrup P, Andersson T, Falck B, Hansson JA, Jacobsson S, Rorsman H, Rosengren E, Rosengren AM.
    Acta Derm Venereol; 1977 Aug 07; 57(2):113-6. PubMed ID: 71802
    [Abstract] [Full Text] [Related]

  • 14. Prognostic value of serum 5-S-cysteinyldopa for monitoring human metastatic melanoma during immunochemotherapy.
    Wimmer I, Meyer JC, Seifert B, Dummer R, Flace A, Burg G.
    Cancer Res; 1997 Nov 15; 57(22):5073-6. PubMed ID: 9371505
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dopa and 5-S-cysteinyldopa in the serum of albino, black, and red guinea pigs.
    Hansson C, Agrup G, Rorsman H, Rosengren E.
    Acta Derm Venereol; 1980 Nov 15; 60(2):155-56. PubMed ID: 6155023
    [Abstract] [Full Text] [Related]

  • 18. Comparison of phaeomelanin and its precursor 5-S-cysteinyldopa in the serum of melanoma patients.
    Wakamatsu K, Yokochi M, Naito A, Kageshita T, Ito S.
    Melanoma Res; 2003 Aug 15; 13(4):357-63. PubMed ID: 12883361
    [Abstract] [Full Text] [Related]

  • 19. Determination of 5-S-cysteinyldopa in plasma and urine using a fully automated solid-phase extraction--high-performance liquid chromatographic method for an improvement of specificity and sensitivity of this prognostic marker of malignant melanoma.
    Hartleb J, Damm Y, Arndt R, Christophers E, Stockfleth E.
    J Chromatogr B Biomed Sci Appl; 1999 Apr 30; 727(1-2):31-42. PubMed ID: 10360420
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.